NCT00833729 The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab Status COMPLETED Phase PHASE4
NCT00819780 PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors Status COMPLETED Phase PHASE2
NCT00818948 Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis Status COMPLETED Phase PHASE1
NCT00813384 A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00808639 Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma Status COMPLETED Phase PHASE2
NCT00807859 Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00802815 Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis Status COMPLETED Phase EARLY_PHASE1
NCT00798655 Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00794261 Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma Status COMPLETED Phase PHASE2
NCT00791011 Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat Status COMPLETED Phase PHASE1
NCT00786058 A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003 Status APPROVED_FOR_MARKETING Phase N/A
NCT00785421 Chemotherapy With or Without Enoxaparin in Pancreatic Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00774943 A Study of AMG 557 in Adults With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT00773734 Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) Status COMPLETED Phase PHASE2
NCT00771030 Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis Status COMPLETED Phase PHASE1/PHASE2
NCT00770848 AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00770536 AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR Status COMPLETED Phase PHASE1